nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ORM1—Bupropion—obesity	0.116	0.253	CbGbCtD
Gefitinib—ALB—obesity	0.0884	1	CbGaD
Gefitinib—CYP2C9—Phentermine—obesity	0.0309	0.0674	CbGbCtD
Gefitinib—CYP3A5—Cimetidine—obesity	0.0288	0.0627	CbGbCtD
Gefitinib—CYP2D6—Phentermine—obesity	0.0283	0.0616	CbGbCtD
Gefitinib—CYP2C9—Bupropion—obesity	0.0263	0.0573	CbGbCtD
Gefitinib—CYP2D6—Bupropion—obesity	0.024	0.0524	CbGbCtD
Gefitinib—CYP3A4—Sibutramine—obesity	0.0237	0.0517	CbGbCtD
Gefitinib—CYP2C19—Cimetidine—obesity	0.0232	0.0506	CbGbCtD
Gefitinib—CYP2D6—Methamphetamine—obesity	0.0226	0.0493	CbGbCtD
Gefitinib—CYP2C9—Cimetidine—obesity	0.0193	0.042	CbGbCtD
Gefitinib—ABCB1—Cimetidine—obesity	0.0187	0.0408	CbGbCtD
Gefitinib—CYP3A4—Benzphetamine—obesity	0.018	0.0392	CbGbCtD
Gefitinib—CYP2D6—Cimetidine—obesity	0.0176	0.0385	CbGbCtD
Gefitinib—CYP3A4—Bupropion—obesity	0.0153	0.0333	CbGbCtD
Gefitinib—CYP2C19—Topiramate—obesity	0.0152	0.0331	CbGbCtD
Gefitinib—CYP3A4—Orlistat—obesity	0.0125	0.0272	CbGbCtD
Gefitinib—CYP3A4—Cimetidine—obesity	0.0112	0.0245	CbGbCtD
Gefitinib—CYP3A4—Topiramate—obesity	0.00734	0.016	CbGbCtD
Gefitinib—ORM1—bile—obesity	0.00509	0.0548	CbGeAlD
Gefitinib—MAP3K19—respiratory system—obesity	0.00208	0.0224	CbGeAlD
Gefitinib—SBK1—pituitary gland—obesity	0.00199	0.0214	CbGeAlD
Gefitinib—MAP2K5—hindbrain—obesity	0.00176	0.019	CbGeAlD
Gefitinib—CHEK2—pituitary gland—obesity	0.00173	0.0186	CbGeAlD
Gefitinib—CHEK2—adipose tissue—obesity	0.00172	0.0185	CbGeAlD
Gefitinib—CSNK1E—islet of Langerhans—obesity	0.00171	0.0184	CbGeAlD
Gefitinib—IRAK4—islet of Langerhans—obesity	0.00169	0.0181	CbGeAlD
Gefitinib—CSNK1E—respiratory system—obesity	0.00162	0.0174	CbGeAlD
Gefitinib—MKNK2—islet of Langerhans—obesity	0.00157	0.0169	CbGeAlD
Gefitinib—IRAK1—islet of Langerhans—obesity	0.00157	0.0169	CbGeAlD
Gefitinib—ERBB3—respiratory system—obesity	0.00156	0.0168	CbGeAlD
Gefitinib—CHEK2—adrenal gland—obesity	0.00155	0.0166	CbGeAlD
Gefitinib—HIPK4—endocrine gland—obesity	0.00152	0.0164	CbGeAlD
Gefitinib—MKNK2—respiratory system—obesity	0.00148	0.016	CbGeAlD
Gefitinib—ORM1—gall bladder—obesity	0.00141	0.0152	CbGeAlD
Gefitinib—CSNK1E—adrenal cortex—obesity	0.00136	0.0146	CbGeAlD
Gefitinib—IRAK4—adrenal cortex—obesity	0.00134	0.0144	CbGeAlD
Gefitinib—MKNK2—adrenal cortex—obesity	0.00125	0.0134	CbGeAlD
Gefitinib—ALB—gall bladder—obesity	0.00124	0.0133	CbGeAlD
Gefitinib—MKNK1—adrenal cortex—obesity	0.00123	0.0132	CbGeAlD
Gefitinib—STK10—respiratory system—obesity	0.00121	0.013	CbGeAlD
Gefitinib—EPHA6—endocrine gland—obesity	0.0012	0.0129	CbGeAlD
Gefitinib—MKNK2—cardiovascular system—obesity	0.00114	0.0122	CbGeAlD
Gefitinib—EGFR—adipose tissue—obesity	0.00114	0.0122	CbGeAlD
Gefitinib—MKNK1—cardiovascular system—obesity	0.00112	0.0121	CbGeAlD
Gefitinib—CSNK1E—pituitary gland—obesity	0.0011	0.0118	CbGeAlD
Gefitinib—CSNK1E—adipose tissue—obesity	0.00109	0.0118	CbGeAlD
Gefitinib—IRAK4—pituitary gland—obesity	0.00108	0.0116	CbGeAlD
Gefitinib—IRAK4—adipose tissue—obesity	0.00108	0.0116	CbGeAlD
Gefitinib—ERBB3—adipose tissue—obesity	0.00105	0.0113	CbGeAlD
Gefitinib—CSNK1E—digestive system—obesity	0.00103	0.0111	CbGeAlD
Gefitinib—EGFR—adrenal gland—obesity	0.00102	0.011	CbGeAlD
Gefitinib—MKNK2—pituitary gland—obesity	0.00101	0.0108	CbGeAlD
Gefitinib—MKNK2—adipose tissue—obesity	0.001	0.0108	CbGeAlD
Gefitinib—IRAK1—adipose tissue—obesity	0.001	0.0108	CbGeAlD
Gefitinib—MKNK1—pituitary gland—obesity	0.000994	0.0107	CbGeAlD
Gefitinib—ERBB3—digestive system—obesity	0.000992	0.0107	CbGeAlD
Gefitinib—MKNK1—adipose tissue—obesity	0.00099	0.0106	CbGeAlD
Gefitinib—CSNK1E—adrenal gland—obesity	0.00098	0.0105	CbGeAlD
Gefitinib—IRAK4—adrenal gland—obesity	0.000965	0.0104	CbGeAlD
Gefitinib—MKNK2—digestive system—obesity	0.000943	0.0102	CbGeAlD
Gefitinib—MKNK1—digestive system—obesity	0.000932	0.01	CbGeAlD
Gefitinib—STK10—cardiovascular system—obesity	0.000924	0.00994	CbGeAlD
Gefitinib—MAP2K5—adrenal cortex—obesity	0.000904	0.00973	CbGeAlD
Gefitinib—MKNK2—adrenal gland—obesity	0.000899	0.00967	CbGeAlD
Gefitinib—IRAK1—adrenal gland—obesity	0.000899	0.00967	CbGeAlD
Gefitinib—Erlotinib—NR1I2—obesity	0.000895	0.138	CrCbGaD
Gefitinib—MKNK1—adrenal gland—obesity	0.000888	0.00955	CbGeAlD
Gefitinib—Bosutinib—RPS6KB1—obesity	0.000856	0.132	CrCbGaD
Gefitinib—CSNK1E—endocrine gland—obesity	0.00085	0.00914	CbGeAlD
Gefitinib—MAP2K5—cardiovascular system—obesity	0.000825	0.00888	CbGeAlD
Gefitinib—ERBB3—endocrine gland—obesity	0.00082	0.00882	CbGeAlD
Gefitinib—STK10—adipose tissue—obesity	0.000815	0.00877	CbGeAlD
Gefitinib—EGFR—liver—obesity	0.000797	0.00857	CbGeAlD
Gefitinib—MKNK2—endocrine gland—obesity	0.00078	0.00839	CbGeAlD
Gefitinib—MKNK1—endocrine gland—obesity	0.00077	0.00828	CbGeAlD
Gefitinib—STK10—digestive system—obesity	0.000767	0.00825	CbGeAlD
Gefitinib—CSNK1E—liver—obesity	0.000766	0.00824	CbGeAlD
Gefitinib—IRAK4—liver—obesity	0.000754	0.00811	CbGeAlD
Gefitinib—ERBB3—liver—obesity	0.000739	0.00795	CbGeAlD
Gefitinib—STK10—adrenal gland—obesity	0.000731	0.00787	CbGeAlD
Gefitinib—MAP2K5—pituitary gland—obesity	0.000731	0.00786	CbGeAlD
Gefitinib—MAP2K5—adipose tissue—obesity	0.000728	0.00783	CbGeAlD
Gefitinib—MKNK2—liver—obesity	0.000703	0.00756	CbGeAlD
Gefitinib—IRAK1—liver—obesity	0.000703	0.00756	CbGeAlD
Gefitinib—MKNK1—liver—obesity	0.000694	0.00747	CbGeAlD
Gefitinib—MAP2K5—adrenal gland—obesity	0.000653	0.00702	CbGeAlD
Gefitinib—STK10—endocrine gland—obesity	0.000634	0.00682	CbGeAlD
Gefitinib—CYP2D6—hindbrain—obesity	0.000588	0.00633	CbGeAlD
Gefitinib—Eye pain—Bupropion—obesity	0.000586	0.00361	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Phentermine—obesity	0.000582	0.00359	CcSEcCtD
Gefitinib—Fatigue—Phentermine—obesity	0.000581	0.00358	CcSEcCtD
Gefitinib—Constipation—Phentermine—obesity	0.000577	0.00355	CcSEcCtD
Gefitinib—Dry skin—Orlistat—obesity	0.000575	0.00354	CcSEcCtD
Gefitinib—STK10—liver—obesity	0.000572	0.00615	CbGeAlD
Gefitinib—Hypokalaemia—Orlistat—obesity	0.000571	0.00352	CcSEcCtD
Gefitinib—MAP2K5—endocrine gland—obesity	0.000566	0.00609	CbGeAlD
Gefitinib—Diarrhoea—Phendimetrazine—obesity	0.000564	0.00348	CcSEcCtD
Gefitinib—Dehydration—Sibutramine—obesity	0.000564	0.00348	CcSEcCtD
Gefitinib—Dermatitis exfoliative—Bupropion—obesity	0.000561	0.00346	CcSEcCtD
Gefitinib—Dry skin—Sibutramine—obesity	0.000556	0.00343	CcSEcCtD
Gefitinib—Hypokalaemia—Sibutramine—obesity	0.000552	0.0034	CcSEcCtD
Gefitinib—Acne—Topiramate—obesity	0.000552	0.0034	CcSEcCtD
Gefitinib—Thrombocytopenia—Cimetidine—obesity	0.000546	0.00337	CcSEcCtD
Gefitinib—Aspartate aminotransferase increased—Sibutramine—obesity	0.000546	0.00337	CcSEcCtD
Gefitinib—Nausea—Benzphetamine—obesity	0.000538	0.00331	CcSEcCtD
Gefitinib—Urticaria—Phentermine—obesity	0.000536	0.0033	CcSEcCtD
Gefitinib—Alanine aminotransferase increased—Sibutramine—obesity	0.000535	0.0033	CcSEcCtD
Gefitinib—Abdominal pain—Phentermine—obesity	0.000533	0.00329	CcSEcCtD
Gefitinib—Pancreatitis—Orlistat—obesity	0.000531	0.00327	CcSEcCtD
Gefitinib—Dyspnoea—Diethylpropion—obesity	0.000523	0.00322	CcSEcCtD
Gefitinib—Hypersensitivity—Phenylpropanolamine—obesity	0.000519	0.0032	CcSEcCtD
Gefitinib—CYP3A5—islet of Langerhans—obesity	0.000515	0.00554	CbGeAlD
Gefitinib—MAP2K5—liver—obesity	0.00051	0.00549	CbGeAlD
Gefitinib—Gastrointestinal disorder—Diethylpropion—obesity	0.000506	0.00312	CcSEcCtD
Gefitinib—Constipation—Diethylpropion—obesity	0.000502	0.00309	CcSEcCtD
Gefitinib—Drug interaction—Topiramate—obesity	0.0005	0.00308	CcSEcCtD
Gefitinib—CYP1A1—respiratory system—obesity	0.000498	0.00535	CbGeAlD
Gefitinib—Minaprine—DRD1—obesity	0.000494	0.076	CrCbGaD
Gefitinib—Dehydration—Bupropion—obesity	0.000492	0.00303	CcSEcCtD
Gefitinib—Nausea—Phendimetrazine—obesity	0.00049	0.00302	CcSEcCtD
Gefitinib—CYP3A5—respiratory system—obesity	0.000487	0.00524	CbGeAlD
Gefitinib—Dry skin—Bupropion—obesity	0.000485	0.00299	CcSEcCtD
Gefitinib—Asthenia—Phentermine—obesity	0.000484	0.00298	CcSEcCtD
Gefitinib—Infestation NOS—Orlistat—obesity	0.000483	0.00298	CcSEcCtD
Gefitinib—Infestation—Orlistat—obesity	0.000483	0.00298	CcSEcCtD
Gefitinib—Fatigue—Cimetidine—obesity	0.000481	0.00297	CcSEcCtD
Gefitinib—Constipation—Cimetidine—obesity	0.000477	0.00294	CcSEcCtD
Gefitinib—Pneumonia—Sibutramine—obesity	0.00047	0.0029	CcSEcCtD
Gefitinib—Urticaria—Diethylpropion—obesity	0.000466	0.00287	CcSEcCtD
Gefitinib—ALB—adrenal gland—obesity	0.000465	0.005	CbGeAlD
Gefitinib—Diarrhoea—Phentermine—obesity	0.000461	0.00284	CcSEcCtD
Gefitinib—ORM1—endocrine gland—obesity	0.00046	0.00495	CbGeAlD
Gefitinib—Hepatobiliary disease—Orlistat—obesity	0.000457	0.00282	CcSEcCtD
Gefitinib—Stomatitis—Sibutramine—obesity	0.000456	0.00281	CcSEcCtD
Gefitinib—Conjunctivitis—Sibutramine—obesity	0.000455	0.0028	CcSEcCtD
Gefitinib—Cystitis noninfective—Topiramate—obesity	0.000453	0.0028	CcSEcCtD
Gefitinib—Melaena—Topiramate—obesity	0.000453	0.0028	CcSEcCtD
Gefitinib—Cystitis—Topiramate—obesity	0.000448	0.00276	CcSEcCtD
Gefitinib—Pancreatitis—Bupropion—obesity	0.000448	0.00276	CcSEcCtD
Gefitinib—Vomiting—Phenylpropanolamine—obesity	0.000448	0.00276	CcSEcCtD
Gefitinib—Haematuria—Sibutramine—obesity	0.000446	0.00275	CcSEcCtD
Gefitinib—Rash—Phenylpropanolamine—obesity	0.000444	0.00274	CcSEcCtD
Gefitinib—Dermatitis—Phenylpropanolamine—obesity	0.000444	0.00274	CcSEcCtD
Gefitinib—Body temperature increased—Cimetidine—obesity	0.000441	0.00272	CcSEcCtD
Gefitinib—Epistaxis—Sibutramine—obesity	0.000441	0.00272	CcSEcCtD
Gefitinib—ABCG2—adrenal cortex—obesity	0.00044	0.00473	CbGeAlD
Gefitinib—Haemoglobin—Orlistat—obesity	0.000436	0.00269	CcSEcCtD
Gefitinib—Hepatitis—Orlistat—obesity	0.000434	0.00267	CcSEcCtD
Gefitinib—Haemorrhage—Orlistat—obesity	0.000434	0.00267	CcSEcCtD
Gefitinib—Dry eye—Topiramate—obesity	0.000429	0.00264	CcSEcCtD
Gefitinib—Vomiting—Phentermine—obesity	0.000429	0.00264	CcSEcCtD
Gefitinib—Urinary tract disorder—Orlistat—obesity	0.000428	0.00264	CcSEcCtD
Gefitinib—Oedema peripheral—Orlistat—obesity	0.000427	0.00263	CcSEcCtD
Gefitinib—Iloperidone—DRD4—obesity	0.000426	0.0655	CrCbGaD
Gefitinib—Urethral disorder—Orlistat—obesity	0.000425	0.00262	CcSEcCtD
Gefitinib—Rash—Phentermine—obesity	0.000425	0.00262	CcSEcCtD
Gefitinib—Dermatitis—Phentermine—obesity	0.000425	0.00262	CcSEcCtD
Gefitinib—Minaprine—HTR2C—obesity	0.000423	0.065	CrCbGaD
Gefitinib—Haemoglobin—Sibutramine—obesity	0.000422	0.0026	CcSEcCtD
Gefitinib—Haemorrhage—Sibutramine—obesity	0.00042	0.00259	CcSEcCtD
Gefitinib—Bladder pain—Topiramate—obesity	0.00042	0.00259	CcSEcCtD
Gefitinib—Mouth ulceration—Topiramate—obesity	0.00042	0.00259	CcSEcCtD
Gefitinib—Nausea—Phenylpropanolamine—obesity	0.000419	0.00258	CcSEcCtD
Gefitinib—ORM1—liver—obesity	0.000414	0.00446	CbGeAlD
Gefitinib—Weight decreased—Bupropion—obesity	0.000414	0.00255	CcSEcCtD
Gefitinib—Oedema peripheral—Sibutramine—obesity	0.000414	0.00255	CcSEcCtD
Gefitinib—Hypersensitivity—Cimetidine—obesity	0.000411	0.00253	CcSEcCtD
Gefitinib—Pneumonia—Bupropion—obesity	0.00041	0.00253	CcSEcCtD
Gefitinib—Infestation NOS—Bupropion—obesity	0.000408	0.00251	CcSEcCtD
Gefitinib—Infestation—Bupropion—obesity	0.000408	0.00251	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Bupropion—obesity	0.000404	0.00249	CcSEcCtD
Gefitinib—Diarrhoea—Diethylpropion—obesity	0.000401	0.00247	CcSEcCtD
Gefitinib—Nausea—Phentermine—obesity	0.000401	0.00247	CcSEcCtD
Gefitinib—Asthenia—Cimetidine—obesity	0.0004	0.00247	CcSEcCtD
Gefitinib—Stomatitis—Bupropion—obesity	0.000397	0.00245	CcSEcCtD
Gefitinib—Conjunctivitis—Bupropion—obesity	0.000396	0.00244	CcSEcCtD
Gefitinib—CYP2C19—digestive system—obesity	0.000393	0.00423	CbGeAlD
Gefitinib—Eye disorder—Sibutramine—obesity	0.000392	0.00242	CcSEcCtD
Gefitinib—Mediastinal disorder—Orlistat—obesity	0.000391	0.00241	CcSEcCtD
Gefitinib—Epistaxis—Bupropion—obesity	0.000384	0.00237	CcSEcCtD
Gefitinib—Alopecia—Orlistat—obesity	0.000383	0.00236	CcSEcCtD
Gefitinib—Diarrhoea—Cimetidine—obesity	0.000382	0.00235	CcSEcCtD
Gefitinib—Angiopathy—Sibutramine—obesity	0.000381	0.00235	CcSEcCtD
Gefitinib—Malnutrition—Orlistat—obesity	0.000378	0.00233	CcSEcCtD
Gefitinib—Hepatic failure—Topiramate—obesity	0.000375	0.00231	CcSEcCtD
Gefitinib—Arrhythmia—Sibutramine—obesity	0.000375	0.00231	CcSEcCtD
Gefitinib—Eye pain—Topiramate—obesity	0.000373	0.0023	CcSEcCtD
Gefitinib—Vomiting—Diethylpropion—obesity	0.000373	0.0023	CcSEcCtD
Gefitinib—Alopecia—Sibutramine—obesity	0.000371	0.00229	CcSEcCtD
Gefitinib—Rash—Diethylpropion—obesity	0.00037	0.00228	CcSEcCtD
Gefitinib—Dermatitis—Diethylpropion—obesity	0.00037	0.00228	CcSEcCtD
Gefitinib—Haemoglobin—Bupropion—obesity	0.000368	0.00227	CcSEcCtD
Gefitinib—CYP2C9—cardiovascular system—obesity	0.000367	0.00395	CbGeAlD
Gefitinib—Haemorrhage—Bupropion—obesity	0.000366	0.00226	CcSEcCtD
Gefitinib—Hepatitis—Bupropion—obesity	0.000366	0.00226	CcSEcCtD
Gefitinib—Malnutrition—Sibutramine—obesity	0.000365	0.00225	CcSEcCtD
Gefitinib—ALB—liver—obesity	0.000363	0.00391	CbGeAlD
Gefitinib—Urinary tract disorder—Bupropion—obesity	0.000361	0.00223	CcSEcCtD
Gefitinib—Iloperidone—DRD1—obesity	0.000361	0.0554	CrCbGaD
Gefitinib—Oedema peripheral—Bupropion—obesity	0.00036	0.00222	CcSEcCtD
Gefitinib—Urethral disorder—Bupropion—obesity	0.000359	0.00221	CcSEcCtD
Gefitinib—ABCG2—pituitary gland—obesity	0.000355	0.00382	CbGeAlD
Gefitinib—Vomiting—Cimetidine—obesity	0.000355	0.00219	CcSEcCtD
Gefitinib—ABCG2—adipose tissue—obesity	0.000354	0.00381	CbGeAlD
Gefitinib—Rash—Cimetidine—obesity	0.000352	0.00217	CcSEcCtD
Gefitinib—Dermatitis—Cimetidine—obesity	0.000352	0.00217	CcSEcCtD
Gefitinib—Minaprine—SLC6A4—obesity	0.00035	0.0539	CrCbGaD
Gefitinib—Minaprine—DRD2—obesity	0.000348	0.0536	CrCbGaD
Gefitinib—Nausea—Diethylpropion—obesity	0.000348	0.00215	CcSEcCtD
Gefitinib—Erythema multiforme—Bupropion—obesity	0.000346	0.00213	CcSEcCtD
Gefitinib—Angioedema—Orlistat—obesity	0.000345	0.00213	CcSEcCtD
Gefitinib—Eye disorder—Bupropion—obesity	0.000342	0.00211	CcSEcCtD
Gefitinib—Malaise—Orlistat—obesity	0.00034	0.0021	CcSEcCtD
Gefitinib—Cardiac disorder—Bupropion—obesity	0.00034	0.00209	CcSEcCtD
Gefitinib—Anaemia—Sibutramine—obesity	0.000338	0.00208	CcSEcCtD
Gefitinib—CYP1A1—adipose tissue—obesity	0.000336	0.00362	CbGeAlD
Gefitinib—Cisapride—HTR2C—obesity	0.000334	0.0514	CrCbGaD
Gefitinib—Angioedema—Sibutramine—obesity	0.000334	0.00206	CcSEcCtD
Gefitinib—Angiopathy—Bupropion—obesity	0.000332	0.00205	CcSEcCtD
Gefitinib—Nausea—Cimetidine—obesity	0.000332	0.00204	CcSEcCtD
Gefitinib—Mediastinal disorder—Bupropion—obesity	0.00033	0.00203	CcSEcCtD
Gefitinib—Malaise—Sibutramine—obesity	0.00033	0.00203	CcSEcCtD
Gefitinib—Cough—Orlistat—obesity	0.000329	0.00203	CcSEcCtD
Gefitinib—CYP3A5—adipose tissue—obesity	0.000329	0.00354	CbGeAlD
Gefitinib—Arrhythmia—Bupropion—obesity	0.000327	0.00202	CcSEcCtD
Gefitinib—CYP2C19—endocrine gland—obesity	0.000324	0.00349	CbGeAlD
Gefitinib—Alopecia—Bupropion—obesity	0.000323	0.00199	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000319	0.00197	CcSEcCtD
Gefitinib—Cough—Sibutramine—obesity	0.000319	0.00197	CcSEcCtD
Gefitinib—Malnutrition—Bupropion—obesity	0.000319	0.00196	CcSEcCtD
Gefitinib—ABCG2—adrenal gland—obesity	0.000318	0.00342	CbGeAlD
Gefitinib—CYP1A1—digestive system—obesity	0.000316	0.0034	CbGeAlD
Gefitinib—Dry mouth—Orlistat—obesity	0.000314	0.00194	CcSEcCtD
Gefitinib—Dehydration—Topiramate—obesity	0.000313	0.00193	CcSEcCtD
Gefitinib—CYP3A5—digestive system—obesity	0.000309	0.00333	CbGeAlD
Gefitinib—Iloperidone—HTR2C—obesity	0.000308	0.0474	CrCbGaD
Gefitinib—Hypokalaemia—Topiramate—obesity	0.000307	0.00189	CcSEcCtD
Gefitinib—Infection—Orlistat—obesity	0.000306	0.00189	CcSEcCtD
Gefitinib—CYP2C9—digestive system—obesity	0.000304	0.00328	CbGeAlD
Gefitinib—Dry mouth—Sibutramine—obesity	0.000304	0.00188	CcSEcCtD
Gefitinib—Toxic epidermal necrolysis—Topiramate—obesity	0.000303	0.00187	CcSEcCtD
Gefitinib—Aspartate aminotransferase increased—Topiramate—obesity	0.000303	0.00187	CcSEcCtD
Gefitinib—Nervous system disorder—Orlistat—obesity	0.000302	0.00186	CcSEcCtD
Gefitinib—Skin disorder—Orlistat—obesity	0.000299	0.00184	CcSEcCtD
Gefitinib—Alanine aminotransferase increased—Topiramate—obesity	0.000297	0.00183	CcSEcCtD
Gefitinib—Infection—Sibutramine—obesity	0.000296	0.00183	CcSEcCtD
Gefitinib—Anaemia—Bupropion—obesity	0.000294	0.00181	CcSEcCtD
Gefitinib—Shock—Sibutramine—obesity	0.000293	0.00181	CcSEcCtD
Gefitinib—CYP2C19—liver—obesity	0.000293	0.00315	CbGeAlD
Gefitinib—Thrombocytopenia—Sibutramine—obesity	0.000292	0.0018	CcSEcCtD
Gefitinib—Angioedema—Bupropion—obesity	0.000291	0.00179	CcSEcCtD
Gefitinib—Skin disorder—Sibutramine—obesity	0.00029	0.00179	CcSEcCtD
Gefitinib—Malaise—Bupropion—obesity	0.000287	0.00177	CcSEcCtD
Gefitinib—Pancreatitis—Topiramate—obesity	0.000286	0.00176	CcSEcCtD
Gefitinib—Anorexia—Sibutramine—obesity	0.000284	0.00175	CcSEcCtD
Gefitinib—Hypotension—Sibutramine—obesity	0.000279	0.00172	CcSEcCtD
Gefitinib—Cough—Bupropion—obesity	0.000278	0.00171	CcSEcCtD
Gefitinib—Cisapride—DRD2—obesity	0.000275	0.0424	CrCbGaD
Gefitinib—ABCB1—islet of Langerhans—obesity	0.000274	0.00295	CbGeAlD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000269	0.00166	CcSEcCtD
Gefitinib—Minaprine—HTR2A—obesity	0.000269	0.0414	CrCbGaD
Gefitinib—Decreased appetite—Orlistat—obesity	0.000268	0.00165	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Orlistat—obesity	0.000266	0.00164	CcSEcCtD
Gefitinib—Dyspnoea—Sibutramine—obesity	0.000266	0.00164	CcSEcCtD
Gefitinib—Fatigue—Orlistat—obesity	0.000266	0.00164	CcSEcCtD
Gefitinib—Dry mouth—Bupropion—obesity	0.000265	0.00163	CcSEcCtD
Gefitinib—Weight decreased—Topiramate—obesity	0.000264	0.00162	CcSEcCtD
Gefitinib—Pain—Orlistat—obesity	0.000264	0.00162	CcSEcCtD
Gefitinib—CYP1A1—endocrine gland—obesity	0.000261	0.00281	CbGeAlD
Gefitinib—Pneumonia—Topiramate—obesity	0.000261	0.00161	CcSEcCtD
Gefitinib—Infestation—Topiramate—obesity	0.00026	0.0016	CcSEcCtD
Gefitinib—Infestation NOS—Topiramate—obesity	0.00026	0.0016	CcSEcCtD
Gefitinib—Decreased appetite—Sibutramine—obesity	0.000259	0.0016	CcSEcCtD
Gefitinib—ABCB1—respiratory system—obesity	0.000258	0.00278	CbGeAlD
Gefitinib—Infection—Bupropion—obesity	0.000258	0.00159	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Topiramate—obesity	0.000257	0.00159	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Sibutramine—obesity	0.000257	0.00159	CcSEcCtD
Gefitinib—Shock—Bupropion—obesity	0.000256	0.00158	CcSEcCtD
Gefitinib—CYP3A5—endocrine gland—obesity	0.000256	0.00275	CbGeAlD
Gefitinib—Pain—Sibutramine—obesity	0.000255	0.00157	CcSEcCtD
Gefitinib—Constipation—Sibutramine—obesity	0.000255	0.00157	CcSEcCtD
Gefitinib—Nervous system disorder—Bupropion—obesity	0.000255	0.00157	CcSEcCtD
Gefitinib—Thrombocytopenia—Bupropion—obesity	0.000255	0.00157	CcSEcCtD
Gefitinib—Iloperidone—DRD2—obesity	0.000254	0.0391	CrCbGaD
Gefitinib—Stomatitis—Topiramate—obesity	0.000253	0.00156	CcSEcCtD
Gefitinib—Skin disorder—Bupropion—obesity	0.000253	0.00156	CcSEcCtD
Gefitinib—Conjunctivitis—Topiramate—obesity	0.000252	0.00156	CcSEcCtD
Gefitinib—Gastrointestinal pain—Orlistat—obesity	0.000252	0.00155	CcSEcCtD
Gefitinib—CYP2C9—endocrine gland—obesity	0.000252	0.00271	CbGeAlD
Gefitinib—ABCG2—liver—obesity	0.000248	0.00267	CbGeAlD
Gefitinib—Anorexia—Bupropion—obesity	0.000248	0.00153	CcSEcCtD
Gefitinib—Haematuria—Topiramate—obesity	0.000248	0.00153	CcSEcCtD
Gefitinib—Epistaxis—Topiramate—obesity	0.000245	0.00151	CcSEcCtD
Gefitinib—Urticaria—Orlistat—obesity	0.000245	0.00151	CcSEcCtD
Gefitinib—Iloperidone—CYP2E1—obesity	0.000245	0.0376	CrCbGaD
Gefitinib—Gastrointestinal pain—Sibutramine—obesity	0.000244	0.0015	CcSEcCtD
Gefitinib—Body temperature increased—Orlistat—obesity	0.000244	0.0015	CcSEcCtD
Gefitinib—Abdominal pain—Orlistat—obesity	0.000244	0.0015	CcSEcCtD
Gefitinib—Hypotension—Bupropion—obesity	0.000243	0.0015	CcSEcCtD
Gefitinib—Urticaria—Sibutramine—obesity	0.000237	0.00146	CcSEcCtD
Gefitinib—Body temperature increased—Sibutramine—obesity	0.000236	0.00145	CcSEcCtD
Gefitinib—Abdominal pain—Sibutramine—obesity	0.000236	0.00145	CcSEcCtD
Gefitinib—CYP1A1—liver—obesity	0.000236	0.00254	CbGeAlD
Gefitinib—Haemoglobin—Topiramate—obesity	0.000234	0.00144	CcSEcCtD
Gefitinib—Hepatitis—Topiramate—obesity	0.000233	0.00144	CcSEcCtD
Gefitinib—Haemorrhage—Topiramate—obesity	0.000233	0.00144	CcSEcCtD
Gefitinib—CYP3A4—digestive system—obesity	0.000232	0.0025	CbGeAlD
Gefitinib—Dyspnoea—Bupropion—obesity	0.000232	0.00143	CcSEcCtD
Gefitinib—CYP3A5—liver—obesity	0.00023	0.00248	CbGeAlD
Gefitinib—Urinary tract disorder—Topiramate—obesity	0.00023	0.00142	CcSEcCtD
Gefitinib—Oedema peripheral—Topiramate—obesity	0.00023	0.00142	CcSEcCtD
Gefitinib—Urethral disorder—Topiramate—obesity	0.000229	0.00141	CcSEcCtD
Gefitinib—CYP2D6—digestive system—obesity	0.000228	0.00246	CbGeAlD
Gefitinib—Hypersensitivity—Orlistat—obesity	0.000227	0.0014	CcSEcCtD
Gefitinib—CYP2C9—liver—obesity	0.000227	0.00244	CbGeAlD
Gefitinib—Decreased appetite—Bupropion—obesity	0.000226	0.00139	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Bupropion—obesity	0.000224	0.00138	CcSEcCtD
Gefitinib—Fatigue—Bupropion—obesity	0.000224	0.00138	CcSEcCtD
Gefitinib—Pain—Bupropion—obesity	0.000222	0.00137	CcSEcCtD
Gefitinib—Constipation—Bupropion—obesity	0.000222	0.00137	CcSEcCtD
Gefitinib—Asthenia—Orlistat—obesity	0.000221	0.00136	CcSEcCtD
Gefitinib—Erythema multiforme—Topiramate—obesity	0.00022	0.00136	CcSEcCtD
Gefitinib—Hypersensitivity—Sibutramine—obesity	0.00022	0.00135	CcSEcCtD
Gefitinib—Pruritus—Orlistat—obesity	0.000218	0.00134	CcSEcCtD
Gefitinib—Eye disorder—Topiramate—obesity	0.000218	0.00134	CcSEcCtD
Gefitinib—ABCB1—adrenal cortex—obesity	0.000217	0.00233	CbGeAlD
Gefitinib—Cardiac disorder—Topiramate—obesity	0.000216	0.00133	CcSEcCtD
Gefitinib—Asthenia—Sibutramine—obesity	0.000214	0.00132	CcSEcCtD
Gefitinib—Cisapride—HTR2A—obesity	0.000213	0.0327	CrCbGaD
Gefitinib—Gastrointestinal pain—Bupropion—obesity	0.000213	0.00131	CcSEcCtD
Gefitinib—Angiopathy—Topiramate—obesity	0.000212	0.0013	CcSEcCtD
Gefitinib—Pruritus—Sibutramine—obesity	0.000211	0.0013	CcSEcCtD
Gefitinib—Diarrhoea—Orlistat—obesity	0.000211	0.0013	CcSEcCtD
Gefitinib—Mediastinal disorder—Topiramate—obesity	0.00021	0.0013	CcSEcCtD
Gefitinib—Urticaria—Bupropion—obesity	0.000207	0.00127	CcSEcCtD
Gefitinib—Alopecia—Topiramate—obesity	0.000206	0.00127	CcSEcCtD
Gefitinib—Body temperature increased—Bupropion—obesity	0.000206	0.00127	CcSEcCtD
Gefitinib—Abdominal pain—Bupropion—obesity	0.000206	0.00127	CcSEcCtD
Gefitinib—Diarrhoea—Sibutramine—obesity	0.000204	0.00126	CcSEcCtD
Gefitinib—Malnutrition—Topiramate—obesity	0.000203	0.00125	CcSEcCtD
Gefitinib—ABCB1—cardiovascular system—obesity	0.000198	0.00213	CbGeAlD
Gefitinib—Iloperidone—HTR2A—obesity	0.000196	0.0302	CrCbGaD
Gefitinib—Vomiting—Orlistat—obesity	0.000196	0.00121	CcSEcCtD
Gefitinib—Rash—Orlistat—obesity	0.000194	0.0012	CcSEcCtD
Gefitinib—Dermatitis—Orlistat—obesity	0.000194	0.0012	CcSEcCtD
Gefitinib—CYP3A4—endocrine gland—obesity	0.000192	0.00206	CbGeAlD
Gefitinib—Hypersensitivity—Bupropion—obesity	0.000192	0.00118	CcSEcCtD
Gefitinib—Vomiting—Sibutramine—obesity	0.00019	0.00117	CcSEcCtD
Gefitinib—CYP2D6—endocrine gland—obesity	0.000189	0.00203	CbGeAlD
Gefitinib—Rash—Sibutramine—obesity	0.000188	0.00116	CcSEcCtD
Gefitinib—Dermatitis—Sibutramine—obesity	0.000188	0.00116	CcSEcCtD
Gefitinib—Anaemia—Topiramate—obesity	0.000188	0.00116	CcSEcCtD
Gefitinib—Asthenia—Bupropion—obesity	0.000187	0.00115	CcSEcCtD
Gefitinib—Pruritus—Bupropion—obesity	0.000184	0.00113	CcSEcCtD
Gefitinib—Nausea—Orlistat—obesity	0.000183	0.00113	CcSEcCtD
Gefitinib—Malaise—Topiramate—obesity	0.000183	0.00113	CcSEcCtD
Gefitinib—Diarrhoea—Bupropion—obesity	0.000178	0.0011	CcSEcCtD
Gefitinib—Nausea—Sibutramine—obesity	0.000177	0.00109	CcSEcCtD
Gefitinib—Cough—Topiramate—obesity	0.000177	0.00109	CcSEcCtD
Gefitinib—ABCB1—pituitary gland—obesity	0.000175	0.00189	CbGeAlD
Gefitinib—ABCB1—adipose tissue—obesity	0.000175	0.00188	CbGeAlD
Gefitinib—CYP3A4—liver—obesity	0.000173	0.00186	CbGeAlD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000172	0.00106	CcSEcCtD
Gefitinib—CYP2D6—liver—obesity	0.00017	0.00183	CbGeAlD
Gefitinib—Dry mouth—Topiramate—obesity	0.000169	0.00104	CcSEcCtD
Gefitinib—Vomiting—Bupropion—obesity	0.000165	0.00102	CcSEcCtD
Gefitinib—Infection—Topiramate—obesity	0.000165	0.00101	CcSEcCtD
Gefitinib—ABCB1—digestive system—obesity	0.000164	0.00177	CbGeAlD
Gefitinib—Rash—Bupropion—obesity	0.000164	0.00101	CcSEcCtD
Gefitinib—Dermatitis—Bupropion—obesity	0.000164	0.00101	CcSEcCtD
Gefitinib—Shock—Topiramate—obesity	0.000163	0.001	CcSEcCtD
Gefitinib—Nervous system disorder—Topiramate—obesity	0.000162	0.001	CcSEcCtD
Gefitinib—Thrombocytopenia—Topiramate—obesity	0.000162	0.001	CcSEcCtD
Gefitinib—Skin disorder—Topiramate—obesity	0.000161	0.000992	CcSEcCtD
Gefitinib—Anorexia—Topiramate—obesity	0.000158	0.000973	CcSEcCtD
Gefitinib—ABCB1—adrenal gland—obesity	0.000157	0.00168	CbGeAlD
Gefitinib—Hypotension—Topiramate—obesity	0.000155	0.000954	CcSEcCtD
Gefitinib—Erlotinib—ALB—obesity	0.000155	0.0238	CrCbGaD
Gefitinib—Nausea—Bupropion—obesity	0.000154	0.000952	CcSEcCtD
Gefitinib—Dyspnoea—Topiramate—obesity	0.000148	0.00091	CcSEcCtD
Gefitinib—Decreased appetite—Topiramate—obesity	0.000144	0.000888	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Topiramate—obesity	0.000143	0.000881	CcSEcCtD
Gefitinib—Fatigue—Topiramate—obesity	0.000143	0.00088	CcSEcCtD
Gefitinib—Pain—Topiramate—obesity	0.000142	0.000873	CcSEcCtD
Gefitinib—Constipation—Topiramate—obesity	0.000142	0.000873	CcSEcCtD
Gefitinib—ABCB1—endocrine gland—obesity	0.000136	0.00146	CbGeAlD
Gefitinib—Gastrointestinal pain—Topiramate—obesity	0.000135	0.000835	CcSEcCtD
Gefitinib—Urticaria—Topiramate—obesity	0.000132	0.000811	CcSEcCtD
Gefitinib—Abdominal pain—Topiramate—obesity	0.000131	0.000807	CcSEcCtD
Gefitinib—Body temperature increased—Topiramate—obesity	0.000131	0.000807	CcSEcCtD
Gefitinib—ABCB1—liver—obesity	0.000122	0.00132	CbGeAlD
Gefitinib—Hypersensitivity—Topiramate—obesity	0.000122	0.000752	CcSEcCtD
Gefitinib—Asthenia—Topiramate—obesity	0.000119	0.000733	CcSEcCtD
Gefitinib—Pruritus—Topiramate—obesity	0.000117	0.000722	CcSEcCtD
Gefitinib—Diarrhoea—Topiramate—obesity	0.000113	0.000699	CcSEcCtD
Gefitinib—Vomiting—Topiramate—obesity	0.000105	0.000649	CcSEcCtD
Gefitinib—Rash—Topiramate—obesity	0.000104	0.000644	CcSEcCtD
Gefitinib—Dermatitis—Topiramate—obesity	0.000104	0.000643	CcSEcCtD
Gefitinib—Vandetanib—ALB—obesity	0.000102	0.0157	CrCbGaD
Gefitinib—Nausea—Topiramate—obesity	9.84e-05	0.000606	CcSEcCtD
Gefitinib—ABCB1—Metabolism—GNB3—obesity	2.59e-06	1.35e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PPARGC1A—obesity	2.59e-06	1.35e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—APOA1—obesity	2.59e-06	1.35e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GNAS—obesity	2.59e-06	1.35e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—HMOX1—obesity	2.58e-06	1.35e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—PIK3CA—obesity	2.57e-06	1.35e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—SERPINE1—obesity	2.57e-06	1.34e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CD36—obesity	2.56e-06	1.34e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—APOB—obesity	2.53e-06	1.32e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PRKAR2B—obesity	2.53e-06	1.32e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PIK3CB—obesity	2.53e-06	1.32e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—AGT—obesity	2.53e-06	1.32e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GNAS—obesity	2.52e-06	1.32e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—DCN—obesity	2.51e-06	1.31e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PTGS2—obesity	2.51e-06	1.31e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TYK2—obesity	2.5e-06	1.31e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—STAT3—obesity	2.5e-06	1.31e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—PIK3CA—obesity	2.48e-06	1.3e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—RHOA—obesity	2.48e-06	1.3e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—COMT—obesity	2.48e-06	1.29e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—APOE—obesity	2.48e-06	1.29e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—APOB—obesity	2.47e-06	1.29e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—COMT—obesity	2.46e-06	1.28e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NOS3—obesity	2.46e-06	1.28e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PIK3R1—obesity	2.46e-06	1.28e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CAV1—obesity	2.45e-06	1.28e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—APOA1—obesity	2.45e-06	1.28e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CPT1A—obesity	2.44e-06	1.28e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PPARGC1A—obesity	2.44e-06	1.28e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GNB3—obesity	2.44e-06	1.28e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—MYC—obesity	2.43e-06	1.27e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—HMOX1—obesity	2.43e-06	1.27e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TGFB1—obesity	2.43e-06	1.27e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—MTHFR—obesity	2.43e-06	1.27e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GNB3—obesity	2.42e-06	1.27e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PPARGC1A—obesity	2.42e-06	1.27e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—LPL—obesity	2.42e-06	1.26e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—HMOX1—obesity	2.41e-06	1.26e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NAMPT—obesity	2.4e-06	1.25e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—LIPC—obesity	2.38e-06	1.25e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GCK—obesity	2.38e-06	1.25e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PPARA—obesity	2.38e-06	1.24e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GNAS—obesity	2.38e-06	1.24e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—APOC3—obesity	2.37e-06	1.24e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PIK3CG—obesity	2.37e-06	1.24e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—LPL—obesity	2.36e-06	1.23e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GPX1—obesity	2.36e-06	1.23e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GNAS—obesity	2.36e-06	1.23e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—PIK3CA—obesity	2.35e-06	1.23e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.34e-06	1.23e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—PIK3CA—obesity	2.34e-06	1.22e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—APOB—obesity	2.33e-06	1.22e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—MYC—obesity	2.32e-06	1.21e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—TGFB1—obesity	2.32e-06	1.21e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—APOB—obesity	2.31e-06	1.21e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—AGT—obesity	2.3e-06	1.2e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GPX1—obesity	2.3e-06	1.2e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CETP—obesity	2.3e-06	1.2e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CD36—obesity	2.3e-06	1.2e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PPARG—obesity	2.28e-06	1.19e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL6—obesity	2.28e-06	1.19e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SDC1—obesity	2.27e-06	1.19e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MTOR—obesity	2.27e-06	1.18e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PIK3CB—obesity	2.27e-06	1.18e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—APOE—obesity	2.26e-06	1.18e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—POMC—obesity	2.25e-06	1.18e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CD36—obesity	2.24e-06	1.17e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—INS—obesity	2.24e-06	1.17e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CAV1—obesity	2.24e-06	1.17e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—AKR1C3—obesity	2.24e-06	1.17e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PIK3CG—obesity	2.24e-06	1.17e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—APOA1—obesity	2.23e-06	1.17e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—LPL—obesity	2.22e-06	1.16e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—LPL—obesity	2.2e-06	1.15e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SCARB1—obesity	2.2e-06	1.15e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL6—obesity	2.2e-06	1.15e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—MTHFR—obesity	2.18e-06	1.14e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GPX1—obesity	2.17e-06	1.13e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PPARG—obesity	2.16e-06	1.13e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GPX1—obesity	2.15e-06	1.12e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.14e-06	1.12e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SREBF1—obesity	2.14e-06	1.12e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—PIK3CA—obesity	2.14e-06	1.12e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PPARA—obesity	2.14e-06	1.12e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—POMC—obesity	2.13e-06	1.11e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—MTHFR—obesity	2.12e-06	1.11e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—INS—obesity	2.12e-06	1.11e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CD36—obesity	2.11e-06	1.1e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—AKT1—obesity	2.1e-06	1.1e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CD36—obesity	2.09e-06	1.09e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PPARA—obesity	2.08e-06	1.09e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PIK3CD—obesity	2.08e-06	1.09e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GOT2—obesity	2.08e-06	1.09e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL6—obesity	2.07e-06	1.08e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—AGT—obesity	2.07e-06	1.08e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—PIK3CA—obesity	2.07e-06	1.08e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ALB—obesity	2.05e-06	1.07e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PIK3CG—obesity	2.04e-06	1.06e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—FASN—obesity	2.03e-06	1.06e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—AKT1—obesity	2.03e-06	1.06e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—APOE—obesity	2.03e-06	1.06e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—BCHE—obesity	2.03e-06	1.06e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—AGT—obesity	2.02e-06	1.06e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CAV1—obesity	2.01e-06	1.05e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—APOA1—obesity	2e-06	1.05e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—MTHFR—obesity	2e-06	1.05e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—MTHFR—obesity	1.98e-06	1.04e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—APOE—obesity	1.98e-06	1.03e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—PIK3CA—obesity	1.97e-06	1.03e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MMP9—obesity	1.97e-06	1.03e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PPARG—obesity	1.97e-06	1.03e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PIK3CD—obesity	1.96e-06	1.03e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PPARA—obesity	1.96e-06	1.03e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PIK3R1—obesity	1.96e-06	1.03e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—NOS3—obesity	1.96e-06	1.03e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CAV1—obesity	1.96e-06	1.02e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—APOA1—obesity	1.96e-06	1.02e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CYP2E1—obesity	1.95e-06	1.02e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PPARA—obesity	1.95e-06	1.02e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ALB—obesity	1.94e-06	1.01e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—POMC—obesity	1.94e-06	1.01e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NQO1—obesity	1.93e-06	1.01e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—INS—obesity	1.93e-06	1.01e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.92e-06	1e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—AKT1—obesity	1.92e-06	1e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MAPK8—obesity	1.92e-06	1e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—AKT1—obesity	1.91e-06	9.99e-06	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—AGT—obesity	1.9e-06	9.94e-06	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL6—obesity	1.89e-06	9.89e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—AGT—obesity	1.89e-06	9.86e-06	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—APOE—obesity	1.86e-06	9.74e-06	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PIK3R1—obesity	1.86e-06	9.7e-06	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—NOS3—obesity	1.86e-06	9.7e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SLC2A4—obesity	1.85e-06	9.68e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GCG—obesity	1.85e-06	9.68e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—APOE—obesity	1.85e-06	9.66e-06	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CAV1—obesity	1.85e-06	9.65e-06	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—APOA1—obesity	1.84e-06	9.63e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CAV1—obesity	1.83e-06	9.57e-06	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL6—obesity	1.83e-06	9.56e-06	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PIK3CG—obesity	1.83e-06	9.56e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CYCS—obesity	1.83e-06	9.56e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—APOA1—obesity	1.83e-06	9.55e-06	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PIK3CB—obesity	1.81e-06	9.47e-06	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PTGS2—obesity	1.8e-06	9.39e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GGT1—obesity	1.79e-06	9.38e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GOT1—obesity	1.79e-06	9.38e-06	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PIK3CD—obesity	1.79e-06	9.36e-06	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PIK3CG—obesity	1.79e-06	9.33e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NCOA1—obesity	1.77e-06	9.24e-06	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PPARG—obesity	1.77e-06	9.23e-06	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—STAT3—obesity	1.75e-06	9.15e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.75e-06	9.14e-06	CbGpPWpGaD
Gefitinib—EGFR—Disease—IL6—obesity	1.75e-06	9.13e-06	CbGpPWpGaD
Gefitinib—EGFR—Immune System—AKT1—obesity	1.75e-06	9.12e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—STK11—obesity	1.74e-06	9.11e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CYP19A1—obesity	1.74e-06	9.11e-06	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—POMC—obesity	1.74e-06	9.1e-06	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—INS—obesity	1.73e-06	9.05e-06	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PPARG—obesity	1.72e-06	9.01e-06	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PIK3CB—obesity	1.71e-06	8.95e-06	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—POMC—obesity	1.7e-06	8.88e-06	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PTGS2—obesity	1.7e-06	8.87e-06	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PIK3R1—obesity	1.69e-06	8.84e-06	CbGpPWpGaD
Gefitinib—ALB—Metabolism—NOS3—obesity	1.69e-06	8.84e-06	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—INS—obesity	1.69e-06	8.83e-06	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—AKT1—obesity	1.69e-06	8.82e-06	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PIK3CG—obesity	1.68e-06	8.79e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PIK3CG—obesity	1.67e-06	8.72e-06	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MYC—obesity	1.63e-06	8.51e-06	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PPARG—obesity	1.62e-06	8.49e-06	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TGFB1—obesity	1.62e-06	8.48e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—COMT—obesity	1.62e-06	8.46e-06	CbGpPWpGaD
Gefitinib—EGFR—Disease—AKT1—obesity	1.61e-06	8.42e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PPARG—obesity	1.61e-06	8.41e-06	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PIK3CD—obesity	1.61e-06	8.4e-06	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—POMC—obesity	1.6e-06	8.37e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PPARGC1A—obesity	1.6e-06	8.35e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GNB3—obesity	1.6e-06	8.35e-06	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—INS—obesity	1.59e-06	8.32e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—HMOX1—obesity	1.59e-06	8.31e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—POMC—obesity	1.59e-06	8.3e-06	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ALB—obesity	1.59e-06	8.3e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—INS—obesity	1.58e-06	8.25e-06	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PIK3CD—obesity	1.57e-06	8.2e-06	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PIK3CB—obesity	1.56e-06	8.16e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GNAS—obesity	1.55e-06	8.13e-06	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ALB—obesity	1.55e-06	8.1e-06	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PTGS2—obesity	1.55e-06	8.09e-06	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PIK3CA—obesity	1.54e-06	8.06e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—APOB—obesity	1.52e-06	7.96e-06	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PIK3R1—obesity	1.52e-06	7.94e-06	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—NOS3—obesity	1.52e-06	7.94e-06	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PIK3R1—obesity	1.48e-06	7.75e-06	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—NOS3—obesity	1.48e-06	7.75e-06	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PIK3CD—obesity	1.48e-06	7.73e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PIK3CD—obesity	1.47e-06	7.66e-06	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ALB—obesity	1.46e-06	7.63e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—LPL—obesity	1.45e-06	7.6e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ALB—obesity	1.45e-06	7.56e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GPX1—obesity	1.42e-06	7.41e-06	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PIK3CB—obesity	1.4e-06	7.33e-06	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—NOS3—obesity	1.4e-06	7.3e-06	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PIK3R1—obesity	1.4e-06	7.3e-06	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PTGS2—obesity	1.39e-06	7.26e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—NOS3—obesity	1.38e-06	7.24e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PIK3R1—obesity	1.38e-06	7.24e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CD36—obesity	1.38e-06	7.22e-06	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PIK3CA—obesity	1.38e-06	7.22e-06	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PIK3CB—obesity	1.37e-06	7.15e-06	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PTGS2—obesity	1.36e-06	7.08e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—MTHFR—obesity	1.31e-06	6.84e-06	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PIK3CB—obesity	1.29e-06	6.74e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PPARA—obesity	1.28e-06	6.71e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PIK3CB—obesity	1.28e-06	6.68e-06	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PTGS2—obesity	1.28e-06	6.68e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PTGS2—obesity	1.27e-06	6.62e-06	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—AKT1—obesity	1.26e-06	6.59e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—AGT—obesity	1.24e-06	6.5e-06	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL6—obesity	1.22e-06	6.39e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—APOE—obesity	1.22e-06	6.37e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CAV1—obesity	1.21e-06	6.31e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—APOA1—obesity	1.2e-06	6.3e-06	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—AKT1—obesity	1.13e-06	5.9e-06	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PIK3CA—obesity	1.11e-06	5.78e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PIK3CG—obesity	1.1e-06	5.75e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PPARG—obesity	1.06e-06	5.55e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—POMC—obesity	1.05e-06	5.47e-06	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PIK3CA—obesity	1.04e-06	5.46e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—INS—obesity	1.04e-06	5.44e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PIK3CD—obesity	9.67e-07	5.05e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ALB—obesity	9.55e-07	4.99e-06	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PIK3CA—obesity	9.52e-07	4.97e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NOS3—obesity	9.13e-07	4.77e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PIK3R1—obesity	9.13e-07	4.77e-06	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—AKT1—obesity	9.03e-07	4.72e-06	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PIK3CA—obesity	8.54e-07	4.47e-06	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—AKT1—obesity	8.53e-07	4.46e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PIK3CB—obesity	8.43e-07	4.4e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTGS2—obesity	8.35e-07	4.36e-06	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PIK3CA—obesity	8.34e-07	4.36e-06	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PIK3CA—obesity	7.86e-07	4.11e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PIK3CA—obesity	7.79e-07	4.07e-06	CbGpPWpGaD
Gefitinib—ALB—Metabolism—AKT1—obesity	7.77e-07	4.06e-06	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—AKT1—obesity	6.98e-07	3.65e-06	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—AKT1—obesity	6.81e-07	3.56e-06	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—AKT1—obesity	6.42e-07	3.36e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—AKT1—obesity	6.36e-07	3.33e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PIK3CA—obesity	5.14e-07	2.69e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—AKT1—obesity	4.2e-07	2.19e-06	CbGpPWpGaD
